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    Acase of pri皿ary transitional cell carcinoma of the prostate was reported． The patient was a
64－year－old man who had cornplained ofthe paih in the right lower abdomen and the right leg． lnitially
it was confirmed that the patient had a ．metastatic adenocarcinoma of the ischial bone by．its biopsy
in the other clinic and he was sent to our hospital．
    The histological diagnosis was rnixed type of transitional cell carcinoma with ’adenocarcinoma
by needle biepsy and transure’ thral resection of the prostate． Nonneoplastic change of the bladder
epithelium was found by random transurethral cold punch biopsy ef the urinary bladder．
    Initially， the treatment consisted oforchiectomy and intravenous administration efdiethylstilbestrol
diphosphate． Oral administration ef Ni一（2－tetrahydrofuryl）一5－fiuorouracil and intramuscular injection
of picibanil were added after the confirmation of histological diagnosis．
    About 2 months later， this treatment proved to be noneffective histologically despite ef decrease
in serum acid phosphatase and prostatic acid phosphatase． Accordingly doxorubicin hydrochloride
was administered for the pext treatment． Doxorubicin hydrochloride was effective on the primary
’lesion， but did not effect on the osseous metastatic lesions． Then finally he was treated with cis－diam－
minedichloroplatinum． The complete disapPeara’nce of primary and osseous metastatic lesions were
shown by roentgenography and bone scanning． Cis－diamminedichloroplatinum appeats to be the
most effective drug for the treatment of advanced transitional cell carcinoma of the prostate．





















































Table 1． Changes of laboratory data during the treatment
Before treatmentAfter hormonemanipulation
 After immunochemotherapy
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It shows that prostatic urethra is crooked and narrow．
Fig． 3． Lymphography： Abnormal findings in the left pelvic region．
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Fig． 4． Bone scintigram： The lesions
    of sterum， pelvi c bones and
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Fig． 6． Histology before therapy： Primary transitional cell carcinoma with adenocarcinoma．
Fig． 7． Histology after therapy with adriamycin： Degenerated changes of the turnor tissues
    are found．
Jt 一
二







Bone scintigram after the treatment
with adnamycm； the lesions of ih－
ac bone and public bone remained
stable．
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Fig． 9． Bone scintigram on January
    24， ’80： New lesions are











Fig． IO． Bone scintigram after the treat－
      meament with cis－diamminedichl－
      oroplatinum ， all the metastatic



















































































































































cin， methotrexate， VM－26， neo¢arzinostatin， hexa－
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